Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.630 USD | +1.88% |
|
+20.74% | -12.83% |
| Capitalization | 492M 418M 386M 364M 675M 45.8B 687M 4.52B 1.77B 22.04B 1.85B 1.81B 78.35B | P/E ratio 2026 * |
-3.15x | P/E ratio 2027 * | -3.57x |
|---|---|---|---|---|---|
| Enterprise value | 492M 418M 386M 364M 675M 45.8B 687M 4.52B 1.77B 22.04B 1.85B 1.81B 78.35B | EV / Sales 2026 * |
2.82x | EV / Sales 2027 * | 2.5x |
| Free-Float |
90.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Pacific Biosciences of California, Inc.
| 1 day | +1.88% | ||
| 1 week | +20.74% | ||
| Current month | +23.48% | ||
| 1 month | +19.85% | ||
| 3 months | -26.24% | ||
| 6 months | -7.39% | ||
| Current year | -12.83% |
| 1 week | 1.33 |  | 1.65 |
| 1 month | 1.23 | | 1.65 |
| Current year | 1.23 | | 2.73 |
| 1 year | 0.85 | | 2.73 |
| 3 years | 0.85 | | 14.55 |
| 5 years | 0.85 | | 36.36 |
| 10 years | 0.85 | | 53.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christian Henry
CEO | Chief Executive Officer | 58 | 14/09/2020 |
Stephen Turner
CTO | Chief Tech/Sci/R&D Officer | 58 | 01/01/2004 |
James Gibson
DFI | Director of Finance/CFO | 57 | 31/03/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Bill Ericson
BRD | Director/Board Member | 67 | 01/01/2004 |
| Director/Board Member | 72 | 01/01/2009 | |
Marshall Mohr
BRD | Director/Board Member | 69 | 18/01/2012 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.54% | 2.87% | 1 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.88% | +20.74% | +35.83% | -85.45% | 492M | |
| -2.95% | +3.11% | +18.13% | -12.37% | 192B | |
| -2.19% | +0.69% | -4.83% | +71.55% | 163B | |
| -2.20% | +0.41% | +1.64% | -23.00% | 137B | |
| -1.84% | +3.49% | -33.42% | +22.50% | 94.25B | |
| +1.41% | +2.30% | -13.48% | -28.02% | 50.39B | |
| +1.09% | -0.13% | +11.03% | -6.29% | 45.58B | |
| -1.27% | +2.48% | +15.14% | -15.05% | 33.42B | |
| -0.42% | +0.40% | +19.06% | -11.13% | 33.4B | |
| -1.78% | -1.43% | +6.26% | +0.07% | 32.59B | |
| Average | +0.73% | +3.47% | +5.54% | -8.72% | 78.17B | |
| Weighted average by Cap. | +0.84% | +2.23% | +1.22% | +7.19% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 174M 148M 137M 129M 239M 16.23B 243M 1.6B 628M 7.81B 654M 641M 27.76B | 197M 167M 154M 145M 270M 18.3B 274M 1.81B 708M 8.8B 738M 722M 31.3B |
| Net income | -161M -136M -126M -119M -220M -14.94B -224M -1.48B -578M -7.19B -602M -590M -25.55B | -151M -128M -118M -111M -207M -14.03B -210M -1.39B -543M -6.75B -566M -554M -24B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 1.630 $ | +1.87% | 5,346,943 |
| 15/04/26 | 1.600 $ | +1.91% | 4,352,036 |
| 14/04/26 | 1.570 $ | +8.28% | 6,339,662 |
| 13/04/26 | 1.450 $ | +8.21% | 4,765,842 |
| 10/04/26 | 1.340 $ | -0.74% | 3,593,928 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PACB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition